Lymphoma, Diffuse Large B-Cell
6 clinical trials · Condition
◉ Watch Lymphoma, Diffuse Large B-Cell
| Record | Firm | Date |
|---|---|---|
| A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers (NCT07226843) | Eli Lilly and Company | 2026-04-17 |
| Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell Malignancies (NCT07284433) | AvenCell Therapeutics, Inc. | 2026-01-06 |
| Comparison of Whole-body MRI, Circulating DNA and PET-CT in Staging, Prognosis, and Treatment Response in Patients with Diffuse Large Cell B Lymphoma (NCT06777290) | Charles University, Czech Republic | 2021-01-01 |
| Pesticide Associated Lymphomas: Expression of Treatment Resistance Genes (NCT03597685) | University Hospital, Montpellier | 2018-02-20 |
| Occupational Exposure to Pesticides in the Prognosis of Lymphomas (NCT02898870) | University Hospital, Montpellier | 2015-07-01 |
| PNT2258 for Treatment of Patients With r/r DLBCL (Wolverine) (NCT02226965) | Sierra Oncology LLC - a GSK company | 2014-12-01 |
Track Lymphoma, Diffuse Large B-Cell automatically
Every clearance here is in the API, with alerts when new ones post.